November 13, 2026
$RichWire Markets and money, explained simply
LIVE
Zai Lab Shares Slip Despite Positive Early Trial Data for Eczema Drug Candidate HawkEye 360 Shares Surge 16% on Strong Sales and Positive Cash Flow Bitcoin Slips Toward $68,000 as Analysts Weigh Resilience of ETF Inflows Hims & Hers Stock Drops 17% on Weak Fourth-Quarter Guidance Amid Upcoming Peptide Expansion Nebius Shares Slide Despite Robust Quarterly Results As Data Center Setbacks Weigh on Outlook Market Pullback Creates Entry Point for KinderCare Learning Stock, Analyst Argues York Space Systems Shares Tumble 16.7% Following Massive Earnings Miss and Cash Burn StoneCo Presents Asymmetric Entry Point Amid Brazilian Interest Rate Pressures Memory Chip Makers Surge as AI Infrastructure Demand Outstrips Supply Through 2030 Lam Research Drops 5% Amid Broader Tech Selloff and Nvidia Leadership Concerns Nvidia Faces Scrutiny as Up to 20% of Asian Revenue Tied to Complex China Supply Chains Bitcoin Million-Dollar Target Unrealistic by 2030, Industry Executive Warns Zai Lab Shares Slip Despite Positive Early Trial Data for Eczema Drug Candidate HawkEye 360 Shares Surge 16% on Strong Sales and Positive Cash Flow Bitcoin Slips Toward $68,000 as Analysts Weigh Resilience of ETF Inflows Hims & Hers Stock Drops 17% on Weak Fourth-Quarter Guidance Amid Upcoming Peptide Expansion Nebius Shares Slide Despite Robust Quarterly Results As Data Center Setbacks Weigh on Outlook Market Pullback Creates Entry Point for KinderCare Learning Stock, Analyst Argues York Space Systems Shares Tumble 16.7% Following Massive Earnings Miss and Cash Burn StoneCo Presents Asymmetric Entry Point Amid Brazilian Interest Rate Pressures Memory Chip Makers Surge as AI Infrastructure Demand Outstrips Supply Through 2030 Lam Research Drops 5% Amid Broader Tech Selloff and Nvidia Leadership Concerns Nvidia Faces Scrutiny as Up to 20% of Asian Revenue Tied to Complex China Supply Chains Bitcoin Million-Dollar Target Unrealistic by 2030, Industry Executive Warns
Home

Topic: Atopic Dermatitis

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.